Neurology

Multiple Sclerosis

Getting patients talking helped secure funding and influence policy for beta-interferons on behalf of Biogen.

Parkinson’s Disease

Talking to patient groups helped identify unmet patient needs enabling the development of innovative resources that improved quality of life and raised the profile of our client Orion Pharm.